HighTower Advisors’s BlackRock Capital Allocation Term Trust BCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$239K Buy
16,919
+619
+4% +$9.12K ﹤0.01% 3354
2025
Q4
$231K Buy
16,300
+602
+4% +$8.71K ﹤0.01% 3250
2025
Q3
$232K Buy
15,698
+2,868
+22% +$42.9K ﹤0.01% 3242
2025
Q2
$194K Buy
12,830
+431
+3% +$6.29K ﹤0.01% 3302
2025
Q1
$179K Buy
+12,399
New +$189K ﹤0.01% 3227
2023
Q1
Sell
-73,594
Closed -$1.02M 3416
2022
Q4
$1.02M Buy
+73,594
New +$1.04M ﹤0.01% 1660
2022
Q2
Sell
-10,248
Closed -$170K 3251
2022
Q1
$170K Hold
10,248
﹤0.01% 2881
2021
Q4
$199K Hold
10,248
﹤0.01% 2779
2021
Q3
$207K Sell
10,248
-12,500
-55% -$270K ﹤0.01% 2683
2021
Q2
$498K Buy
+22,748
New +$483K ﹤0.01% 2050

Other funds holding BCAT

HighTower Advisors's BCAT Position: Q1 2026 in Review

HighTower Advisors increased its BlackRock Capital Allocation Term Trust (BCAT) stake by 3.8% in Q1 2026, buying an estimated $9.12K and bringing the position to 16,919 shares worth $239K. The position accounts for ﹤0.01% of the portfolio, ranked #3354.

HighTower Advisors first reported a position in BCAT in Q2 2021 and has held it in 10 quarters since. The position peaked at $1.02M in Q4 2022. 100 funds tracked by Wall St. Rank hold BCAT as of Q1 2026.

  • HighTower Advisors held 16,919 shares of BlackRock Capital Allocation Term Trust worth $239K as of Q1 2026.
  • HighTower Advisors bought 619 BlackRock Capital Allocation Term Trust shares in Q1 2026, an estimated $9.12K.
  • BlackRock Capital Allocation Term Trust made up ﹤0.01% of HighTower Advisors's portfolio in Q1 2026, its #3354 holding.
  • HighTower Advisors first reported a position in BlackRock Capital Allocation Term Trust in Q2 2021 and has held it in 10 quarters since.
  • HighTower Advisors's BlackRock Capital Allocation Term Trust position peaked at $1.02M in Q4 2022.
  • 100 funds tracked by Wall St. Rank held BlackRock Capital Allocation Term Trust as of Q1 2026.

Based on HighTower Advisors's 13F filing for Q1 2026, filed 5 May 2026.